|
|
|
Volumn 28, Issue 1, 2003, Pages 65-71
|
|
Off-label use of clopidogrel after coronary stent implantation in Germany: optional or mandatory?;"Off-Label"-Verschreibung von Clopidogrel nach Stentimplantation: verzichtbar oder zwingend?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
CLOPIDOGREL;
DRUG DERIVATIVE;
NEW DRUG;
TICLOPIDINE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY OBSTRUCTION;
DRUG APPROVAL;
DRUG COMBINATION;
DRUG COST;
ECONOMICS;
FINANCIAL MANAGEMENT;
GERMANY;
HUMAN;
LEGAL ASPECT;
PRESCRIPTION;
PUBLIC HEALTH;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
STENT;
TREATMENT OUTCOME;
ASPIRIN;
CORONARY RESTENOSIS;
CORONARY STENOSIS;
DRUG APPROVAL;
DRUG COSTS;
DRUG THERAPY, COMBINATION;
DRUGS, INVESTIGATIONAL;
FINANCING, PERSONAL;
GERMANY;
HUMANS;
NATIONAL HEALTH PROGRAMS;
PRESCRIPTIONS, DRUG;
RANDOMIZED CONTROLLED TRIALS;
STENTS;
TICLOPIDINE;
TREATMENT OUTCOME;
|
|
EID: 0038673813
PISSN: 03409937
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
